Skip to main content
. 2020 Aug 29;34(12):e23511. doi: 10.1002/jcla.23511

FIGURE 1.

FIGURE 1

Serum levels of miR‐212 were significantly upregulated in gastric patients and related to GC stages. A, Mann‐Whitney test showed that serum levels of miR‐212 in non‐cancer donors was significantly higher than that in GC patients. B, miR‐212 serum level was higher in GC stage I‐II than that in GC stage III‐IV. C, miR‐212 serum level was higher after therapy in overall GC stages. D, miR‐212 serum level was higher after therapy in GC stage I‐II. E, miR‐212 serum level was higher after therapy in GC stage III‐IV